Investment Summary |
|
|---|---|
| Date | 2013-07-25 |
| Target | Conatus Pharmaceuticals |
| Sector | Life Science |
| Investor(s) | Bay City Capital |
| Deal Type | PIPE |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 70 of 75 |
| Sector: Life Science M&A | 50 of 54 |
| Type: PIPE M&A Deals | 4 of 4 |
| State: California M&A | 39 of 41 |
| Country: United States M&A | 67 of 72 |
| Year: 2013 M&A | 6 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-15 |
IDEV Technologies
Webster, Texas, United States IDEV Technologies is provider of medical devices for use in interventional radiology, vascular surgery, and cardiology. |
Sell | $310M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-01 |
Civitas Therapeutics
Chelsea, Massachusetts, United States Civitas Therapeutics, Inc. is a biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically proven ARCUS® dry powder pulmonary delivery platform. |
Buy | - |
